ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1580565
Chemotherapy-Induced Alterations in miRNA Expression and Their Prognostic Implications in Ovarian Cancer
Provisionally accepted
Samruddhi Ranmale1
Pavan Kumar1
Hemant Tongaonkar2
Sanket Mehta3Vashisth Maniar3
Jayanti Mania-Pramanik1*- 1ICMR-National Institute for Research in Reproductive and Child Health, Mumbai, India
- 2P. D. Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India
- 3Saifee Hospital, Mumbai, Maharashtra, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Ovarian cancer has a high mortality rate due to late diagnosis, relapse and chemoresistance. miRNAs play a major role in tumorigenesis as well as chemoresistance. Hence, we undertook a study, to evaluate the differential expression of miRNAs in clinical specimens of ovarian cancer patients that may highlight the effect of chemotherapy and their role in predicting survival outcomes. Methods:Clinical specimens were collected from n=127 participants comprisingchemo-naive, chemo-treated ovarian cancer patients and healthy women as controls for the study. miRNA expression was evaluated by quantitative real-time PCR analysis. Results: Our results indicate an upregulation of miR-182 and miR-130a in the serum of treated ovarian cancer patients, which may be an effect of chemotherapy. Tissue levels of miR-182 and miR-106a were elevated in patients with advanced-stage disease. Elevated tissue expression of miR-106a was also associated with poorchemotherapy responseand early relapse, while miR-200a was elevated in metastatic patients and linked to early relapse.However, reduced tumor suppressor miR-433 and miR-145 levels were observed in metastatic patients. Multivariate Cox regression identified serum miR-130a and tissue miR-20a as independent predictors of progression-free survival. A combined serum miRNA panel (miR-182, miR-106a, miR-23b) demonstrated diagnostic potential with an AUC of 0.743. Conclusion: The study highlights differential regulation of circulating and tissue miRNAs in Indian OC patients, emphasizing the selective retention of oncogenic miRNAs in tumors and release of tumor suppressive miRNAs into circulation. These findings support the utility of miRNAs as diagnostic and prognostic biomarkers in OC.
Keywords: miRNA, ovarian cancer, Clinical specimens, chemotherapy, expression profiling
Received: 20 Feb 2025; Accepted: 21 Jul 2025.
Copyright: © 2025 Ranmale, Kumar, Tongaonkar, Mehta, Maniar and Mania-Pramanik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jayanti Mania-Pramanik, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.